BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 836315)

  • 1. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and biological activity of glycosylated analogs of somatostatin.
    Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R
    Biochem Biophys Res Commun; 1979 Nov; 91(2):614-22. PubMed ID: 518658
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosylated analogues of somatostatin.
    Rivier JE; Brown MR; Vale WW
    J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule.
    Rivier J; Brown M; Vale W
    Biochem Biophys Res Commun; 1975 Jul; 65(2):746-51. PubMed ID: 1096897
    [No Abstract]   [Full Text] [Related]  

  • 8. Analogs of somatostatin. Part A. Chemistry and in vitro results.
    Immer H; Abraham NA; Nelson V; Sestanj K; Götz M; Brazeau P; Martin JB
    Curr Top Mol Endocrinol; 1976; 3():373-8. PubMed ID: 1052675
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel cyclic undercapeptide, WY-40, 770, with prolonged growth hormone release inhibiting activity.
    Sarantakis D; Teichman J; Lien EL; Fenichel RL
    Biochem Biophys Res Commun; 1976 Nov; 73(2):336-42. PubMed ID: 999714
    [No Abstract]   [Full Text] [Related]  

  • 10. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity.
    Garsky VM; Clark DE; Grant NH
    Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple forms of somatostatin-like activity in rat hypothalamus.
    Spiess J; Vale W
    Biochemistry; 1980 Jun; 19(13):2861-6. PubMed ID: 6104982
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.
    Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1317-25. PubMed ID: 143285
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoreactive and biologically active somatostatin-like material in the human retina.
    Rorstad OP; Senterman MK; Hoyte KM; Martin JB
    Brain Res; 1980 Oct; 199(2):488-92. PubMed ID: 6106523
    [No Abstract]   [Full Text] [Related]  

  • 16. Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies.
    Hocart SJ; Reddy V; Murphy WA; Coy DH
    J Med Chem; 1995 May; 38(11):1974-89. PubMed ID: 7783129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
    Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
    Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep.
    Bryce D; Yeh M; Funderburk C; Todd H; Hertelendy F
    Diabetes; 1975 Sep; 24(9):842-50. PubMed ID: 169176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological actions of prosomatostatin.
    Meyers CA; Murphy WA; Redding TW; Coy DH; Schally AV
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6171-4. PubMed ID: 6108563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
    Efendić S; Luft R; Sievertsson H
    FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.